Emerging biopharma companies face pressures that make this type of connected foundation challenging to achieve, particularly in today’s compressed launch timelines: establishing data and analytics capabilities for the first time—with limited resources— and amid launch uncertainty.

In this white paper by Beghou’s experts, explore what first-time launch companies need for AI, analytics, and scalable operations.